| Heart Failure (HF) |
1 |
1 |
| Hypotension |
0 |
0.84 |
| Hypertension |
0 |
0.5 |
| Arrhythmia |
0 |
0.32 |
| Cardiovascular Imaging |
0 |
0.24 |
| Heart |
0 |
0.24 |
| Myocardial Infarction (MI) |
0 |
0.19 |
| Angiotensin II Receptor Blockade |
0 |
0.17 |
| B-Type Natriuretic Peptide |
0 |
0.17 |
| Calcium Channel Blockers |
0 |
0.17 |
| Patient Safety |
0 |
0.17 |
| Adherence |
0 |
0.12 |
| Adverse Effects |
0 |
0.12 |
| Blood |
0 |
0.12 |
| Brain |
0 |
0.12 |
| Calcium |
0 |
0.12 |
| Clinical Research |
0 |
0.12 |
| Diuretics |
0 |
0.12 |
| Dizziness |
0 |
0.12 |
| Ejection Fraction |
0 |
0.12 |
| Europe |
0 |
0.12 |
| Hospital |
0 |
0.12 |
| New York |
0 |
0.12 |
| Receptors |
0 |
0.12 |
| Healthcare and Medical Technology |
0 |
0.11 |
| Osteoarthritis |
0 |
0.11 |